261 related articles for article (PubMed ID: 22296885)
1. Effect of Omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease.
Mackay I; Ford I; Thies F; Fielding S; Bachoo P; Brittenden J
Atherosclerosis; 2012 Apr; 221(2):514-20. PubMed ID: 22296885
[TBL] [Abstract][Full Text] [Related]
2. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers.
Din JN; Archer RM; Harding SA; Sarma J; Lyall K; Flapan AD; Newby DE
Heart; 2013 Feb; 99(3):168-74. PubMed ID: 23184014
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
4. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
5. Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia.
Serebruany VL; Miller M; Pokov AN; Lynch D; Jensen JK; Hallén J; Atar D
Cardiology; 2011; 118(3):187-94. PubMed ID: 21701167
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327
[TBL] [Abstract][Full Text] [Related]
7. Combined aspirin and cilostazol treatment is associated with reduced platelet aggregation and prevention of exercise-induced platelet activation.
Cleanthis M; Bhattacharya V; Smout J; Ashour H; Stansby G
Eur J Vasc Endovasc Surg; 2009 May; 37(5):604-10. PubMed ID: 19297212
[TBL] [Abstract][Full Text] [Related]
8. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
9. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease.
McEwen BJ; Morel-Kopp MC; Chen W; Tofler GH; Ward CM
Semin Thromb Hemost; 2013 Feb; 39(1):25-32. PubMed ID: 23329646
[TBL] [Abstract][Full Text] [Related]
10. Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects.
Phang M; Lincz L; Seldon M; Garg ML
J Nutr Biochem; 2012 Sep; 23(9):1128-33. PubMed ID: 22137256
[TBL] [Abstract][Full Text] [Related]
11. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
13. N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention.
Mizia-Stec K; Mizia M; Haberka M; Lasota B; Gieszczyk-Strózik K; Chmiel A; Najda J; Gąsior Z; Kyrcz-Krzemień S
Cardiol J; 2013; 20(5):478-85. PubMed ID: 24469870
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS
Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557
[TBL] [Abstract][Full Text] [Related]
15. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
[TBL] [Abstract][Full Text] [Related]
16. No effect of omega-3 polyunsaturated fatty acid supplementation on inflammatory markers in familial hypercholesterolemia: a randomized crossover trial.
Hande LN; Thunhaug H; Ludviksen J; Hovland A; Lappegård KT
Scand J Clin Lab Invest; 2023 May; 83(3):152-159. PubMed ID: 36999528
[TBL] [Abstract][Full Text] [Related]
17. Effect of omega-3 fatty acid supplementation on platelet aggregability and platelet produced thromboxane.
Salonen R; Nikkari T; Seppänen K; Venäläinen JM; Ihanainen M; Rissanen V; Rauramaa R; Salonen JT
Thromb Haemost; 1987 Jun; 57(3):269-72. PubMed ID: 3660329
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication.
Cassar K; Bachoo P; Ford I; McGee M; Greaves M; Brittenden J
J Vasc Surg; 2004 Mar; 39(3):560-4. PubMed ID: 14981449
[TBL] [Abstract][Full Text] [Related]
19. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.
Irish A; Dogra G; Mori T; Beller E; Heritier S; Hawley C; Kerr P; Robertson A; Rosman J; Paul-Brent PA; Starfield M; Polkinghorne K; Cass A
BMC Nephrol; 2009 Jan; 10():1. PubMed ID: 19159453
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
